Top & Current
Tue, June 27, 2023
[ Tue, Jun 27th 2023
] - WOPRAI
Fri, August 5, 2022
[ Fri, Aug 05th 2022
] - WOPRAI
Fri, February 25, 2022
[ Fri, Feb 25th 2022
] - WOPRAI
Tue, December 21, 2021
[ Tue, Dec 21st 2021
] - WOPRAI
Wed, November 3, 2021
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
Mon, August 9, 2021
[ Mon, Aug 09th 2021
] - WOPRAI
Thu, July 29, 2021
[ Thu, Jul 29th 2021
] - WOPRAI
Wed, April 28, 2021
[ Wed, Apr 28th 2021
] - WOPRAI
Thu, August 20, 2020
[ Thu, Aug 20th 2020
] - WOPRAI
Fri, May 8, 2020
[ Fri, May 08th 2020
] - WOPRAI
Wed, March 18, 2020
[ Wed, Mar 18th 2020
] - WOPRAI
Fri, January 24, 2020
Wed, April 4, 2018
Fri, September 15, 2017
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
Tue, February 21, 2017
[ Tue, Feb 21st 2017
] - WOPRAI
Mon, January 23, 2017
[ Mon, Jan 23rd 2017
] - WOPRAI
Tue, March 22, 2016
[ Tue, Mar 22nd 2016
] - WOPRAI
Thu, March 3, 2016
[ Thu, Mar 03rd 2016
] - WOPRAI
Fri, February 26, 2016
[ Fri, Feb 26th 2016
] - WOPRAI
Thu, June 18, 2015
[ Thu, Jun 18th 2015
] - WOPRAI
Kennen MacKay Maintained (AGIO) at Buy with Increased Target to $42 on, Jun 27th, 2023
Kennen MacKay of RBC Capital, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $40 to $42 on, Jun 27th, 2023.
Kennen, nor any peers, have made any analyst calls on AGIO in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30